Our novel drug delivery technologies, both polymers and hydrogels, are designed to improve the kinetic profiles of drugs and thereby capitalize on market opportunities because:
There are particular therapeutic areas in the animal health market that are relatively underserved. The treatment of post-operative pain for the care of companion animals, for instance, could be greatly enhanced if a longer duration of action (three to five days) could be achieved and if anti-pruritic (anti-itching) medication could be provided in a single dose. Cytogel's hydrogel and polymer technologies have properties that are appropriate for ehancing the pharmacologic properties of veterinary medicines, which the company may evaluate through proof of concept development. In addition, this hydrogel delivery system could be developed for use in delivering growth hormone products in a sustained release fashion for use with livestock.